Albireo

Provider of bile-acid modulators to treat pediatric and adult cholestatic liver diseases.

Albireo is tracked in the Tech.eu funding database. Based in Boston, United States; active in Healthtech. Acquired by Ipsen in 2023. Data as of 25 Oct 2026.